Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Hypoxia Inducible Factor 1 Alpha – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Islet Amyloid Polypeptide – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary Islet…
DUBLIN–(BUSINESS WIRE)–The “Histone Deacetylase 8 – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary Histone…
DUBLIN–(BUSINESS WIRE)–The “Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Tyrosine Protein Kinase Fyn – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking…
Company signs option agreement with The Rockefeller University to access intellectual property covering compounds targeting key regeneration pathway BOSTON–(BUSINESS WIRE)–Decibel…
Biotech veteran Laurence Reid to lead company as CEO Steven Holtzman retires BOSTON–(BUSINESS WIRE)–Decibel Therapeutics, a development-stage biotechnology company advancing…
HIGHLIGHTS First human dosing of PlexarisTM has occurred in Exopharm’s PLEXOVAL Study PLEXOVAL is a world-first study using a cell…
MIDLAND, Mich.–(BUSINESS WIRE)–Dow (NYSE: DOW): FINANCIAL HIGHLIGHTS GAAP loss per share from continuing operations was $3.14; Operating EPS¹ was $0.78.…